📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. (2012)

First Author: Malard F

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bbmt.2011.10.003

PubMed Identifier: 22001752

Publication URI: http://europepmc.org/abstract/MED/22001752

Type: Journal Article/Review

Volume: 18

Parent Publication: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Issue: 2

ISSN: 1083-8791